8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.51%
Revenue growth under 50% of 2127.T's 62.48%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-2.33%
Negative gross profit growth while 2127.T is at 58.08%. Joel Greenblatt would examine cost competitiveness or demand decline.
-4.92%
Negative EBIT growth while 2127.T is at 85.70%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.57%
Negative operating income growth while 2127.T is at 81.82%. Joel Greenblatt would press for urgent turnaround measures.
-5.25%
Negative net income growth while 2127.T stands at 93.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.25%
Negative EPS growth while 2127.T is at 93.26%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.25%
Negative diluted EPS growth while 2127.T is at 93.26%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.89%
10Y revenue/share CAGR under 50% of 2127.T's 420.86%. Michael Burry would suspect a lasting competitive disadvantage.
2.89%
5Y revenue/share CAGR under 50% of 2127.T's 420.86%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.33%
Negative 3Y CAGR while 2127.T stands at 123.32%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR in line with 2127.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
100.00%
5Y OCF/share CAGR is similar to 2127.T's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
100.00%
Positive 3Y OCF/share CAGR while 2127.T is negative. John Neff might see a big short-term edge in operational efficiency.
79.77%
Below 50% of 2127.T's 1481.10%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
79.77%
Below 50% of 2127.T's 1481.10%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-8.48%
Negative 3Y CAGR while 2127.T is 146.11%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
37.97%
Below 50% of 2127.T's 131.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
37.97%
Below 50% of 2127.T's 131.38%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-7.15%
Negative 3Y equity/share growth while 2127.T is at 78.11%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.88%
Firm’s AR is declining while 2127.T shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.67%
Inventory growth well above 2127.T's 5.30%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.78%
Asset growth well under 50% of 2127.T's 11.44%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.84%
Under 50% of 2127.T's 8.66%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-13.52%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-1.33%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.